{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T05:05:33Z","timestamp":1780031133981,"version":"3.53.1"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Backgrounds<\/jats:title>\n                    <jats:p>Diabetes is associated with alterations in bone marrow (BM) cellularity beyond its acute and chronic complications in both type 1 and type 2 diabetes. These changes may be amplified in patients with advanced disease, such as CLTI. Key alterations include imbalance of the BM microenvironment and shifts in hematopoietic cell populations, particularly the CD34+ subpopulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective observational study analyzed patients treated with autologous cell therapy (ACT) for chronic limb-threatening ischemia over 16 years. Patients on immunosuppressive therapy or corticoids, with stage 4\u20135 chronic kidney disease, repeated ACT were excluded. Harvested BM underwent hematological analysis (leucocytes, monocytes, lymphocytes) and immunophenotyping (percentage and absolute count of CD34). Outcomes were evaluated in relation to diabetes parameters (type, duration, glycated hemoglobin, diabetic complications score index - DCSI) and medications (oral antidiabetics, statins). Wilcoxon rank test and Spearman correlation were used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventy-four patients were included from 167 in the ACT database. Statin therapy was significantly associated with higher CD34 percentage (\u03b2 = 0.256, p&amp;lt; 0.001), while simultaneously being associated with lower lymphocyte counts, suggesting that statins may modify BM cellular composition rather than directly increase absolute progenitor cell numbers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Statins appear to optimize the BM microenvironment rather than increase absolute hematopoietic cell numbers in a non-hematological diabetic population with severe limb ischemia. In addition, higher DCSI scores were associated with increased CD34+ cell percentage, suggesting a link between diabetes severity and BM cellular composition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1850519","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:54:55Z","timestamp":1780030495000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Bone marrow cellular profile in patients with diabetes: association of statin therapy with CD34+ cells"],"prefix":"10.3389","volume":"17","author":[{"given":"Dominika","family":"Sojakova","sequence":"first","affiliation":[{"name":"Diabetes Centre, Institute for Clinical and Experimental Medicine","place":["Videnska, Prague, Czechia"]},{"name":"First Faculty of Medicine Charles University","place":["Katerinska, Prague, Czechia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetiana","family":"Osadcha","sequence":"additional","affiliation":[{"name":"Department of Data Science, Institute for Clinical and Experimental Medicine","place":["Videnska, Prague, Czechia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludek","family":"Horvath","sequence":"additional","affiliation":[{"name":"Diabetes Centre, Institute for Clinical and Experimental Medicine","place":["Videnska, Prague, Czechia"]},{"name":"First Faculty of Medicine Charles University","place":["Katerinska, Prague, Czechia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitka","family":"Husakova","sequence":"additional","affiliation":[{"name":"Diabetes Centre, Institute for Clinical and Experimental Medicine","place":["Videnska, Prague, Czechia"]},{"name":"First Faculty of Medicine Charles University","place":["Katerinska, Prague, Czechia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladim\u00edra","family":"Fejfarova","sequence":"additional","affiliation":[{"name":"Diabetes Centre, Institute for Clinical and Experimental Medicine","place":["Videnska, Prague, Czechia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Sutoris","sequence":"additional","affiliation":[{"name":"Transplantation Surgery Department, Institute for Clinical and Experimental Medicine","place":["Videnska, Prague, Czechia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radka","family":"Jarosikova","sequence":"additional","affiliation":[{"name":"Diabetes Centre, Institute for Clinical and Experimental Medicine","place":["Videnska, Prague, Czechia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Dubsky","sequence":"additional","affiliation":[{"name":"Diabetes Centre, Institute for Clinical and Experimental Medicine","place":["Videnska, Prague, Czechia"]},{"name":"First Faculty of Medicine Charles University","place":["Katerinska, Prague, Czechia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"B1","volume-title":"IDF Diabetes Atlas","year":"2025"},{"key":"B2","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1161\/ATVBAHA.109.200154","article-title":"Diabetes mellitus induces bone marrow microangiopathy","volume":"30","author":"Oikawa","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1530\/JOE-14-0514","article-title":"Type 2 diabetes alters bone and marrow blood flow and vascular control mechanisms in the ZDF rat","volume":"225","author":"Stabley","year":"2015","journal-title":"J Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0894","article-title":"Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1","volume":"63","author":"Albiero","year":"2014","journal-title":"Diabetes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2014-0052","article-title":"Concise review: diabetes, the bone marrow niche, and impaired vascular regeneration","volume":"3","author":"Fadini","year":"2014","journal-title":"Stem Cells Transl Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4931","article-title":"Bone marrow adiposity alterations in type 2 diabetes are sex-specific and associated with serum lipid levels","volume":"38","author":"Wu","year":"2023","journal-title":"J Bone Miner Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41420-023-01708-3","article-title":"Pathological roles of bone marrow adipocyte-derived monocyte chemotactic protein-1 in type 2 diabetic mice","volume":"9","author":"Wan","year":"2023","journal-title":"Cell Death Discov"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/stmcls\/sxab011","article-title":"Impaired bone fracture healing in type 2 diabetes is caused by defective functions of skeletal progenitor cells","volume":"40","author":"Figeac","year":"2022","journal-title":"Stem Cells"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072476","article-title":"Impact of type 2 diabetes mellitus on human bone marrow stromal cell number and phenotypic characteristics","volume":"21","author":"Cassidy","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.112.300598","article-title":"Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155\/FOXO3a signaling pathway","volume":"112","author":"Spinetti","year":"2013","journal-title":"Circ Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/cd21-0091","article-title":"Assessment of the relationship between CD34 antigen and vitamin D level and insulin resistance in patients with type 2 diabetes","volume":"40","author":"Pouresmaeil","year":"2022","journal-title":"Clin Diabetes"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010012","article-title":"Abnormal DNA methylation induced by hyperglycemia reduces CXCR 4 gene expression in CD 34(+) stem cells","volume":"8","author":"Vigorelli","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-02187","article-title":"Effects of hypoglycemia on circulating stem and progenitor cells in diabetic patients","volume":"103","author":"Fadini","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","first-page":"42","article-title":"Clinical use of statins in hematopoietic stem cell transplantation: Old drugs and new horizons","volume":"10","author":"Mohammadi","year":"2016","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12040922","article-title":"Atorvastatin treatment significantly increased the concentration of bone marrow-derived mononuclear cells and transcutaneous oxygen pressure and lowered the pain scale after bone marrow cells treatment in patients with \"No-Option\" critical limb ischaemia","volume":"12","author":"Kyselovic","year":"2024","journal-title":"Biomedicines"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00406.2014","article-title":"The impact of statins on biological characteristics of stem cells provides a novel explanation for their pleiotropic beneficial and adverse clinical effects","volume":"309","author":"Izadpanah","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"B17","first-page":"57","article-title":"The evolving role of statins in hematopoietic stem and progenitor cell transplantation","volume":"1","author":"Hamadani","year":"2011","journal-title":"Am J Blood Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"20267","DOI":"10.1038\/s41598-024-71318-1","article-title":"Metformin enhances osteogenic differentiation of BMSC by modulating macrophage M2 polarization","volume":"14","author":"Fan","year":"2024","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1465697","article-title":"Metformin-mediated effects on mesenchymal stem cells and mechanisms: proliferation, differentiation and aging","volume":"15","author":"Liu","year":"2024","journal-title":"Front Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04598.x","article-title":"Angiotensin I-converting enzyme is expressed by erythropoietic cells of normal and myeloproliferative bone marrow","volume":"123","author":"Marusic-Vrsalovic","year":"2003","journal-title":"Br J Haematol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-018-0677-y","article-title":"Role of the angiotensin-converting enzyme in the G-CSF-induced mobilization of progenitor cells","volume":"113","author":"Kohlstedt","year":"2018","journal-title":"Basic Res Cardiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2017.09.026","article-title":"Update on anemia in ESRD and earlier stages of CKD: Core curriculum 2018","volume":"71","author":"Fishbane","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare9111452","article-title":"Bone marrow hypocellularity in patients with end-stage kidney disease","volume":"9","author":"Hsieh","year":"2021","journal-title":"Healthcare (Basel)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/cyto.b.20612","article-title":"ISHAGE protocol: are we doing it correctly","volume":"82","author":"Whitby","year":"2012","journal-title":"Cytometry B Clin Cytom"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2017.02.018","article-title":"Diabetes complications severity index (DCSI)-update and ICD-10 translation","volume":"31","author":"Glasheen","year":"2017","journal-title":"J Diabetes Complications"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1128134","article-title":"CD34 positive cells as endothelial progenitor cells in biology and medicine","volume":"11","author":"Hassanpour","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.1009160","article-title":"Markers for human haematopoietic stem cells: The disconnect between an identification marker and its function","volume":"13","author":"Rix","year":"2022","journal-title":"Front Physiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: Executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063126","article-title":"Rosuvastatin enhances angiogenesis via eNOS-dependent mobilization of endothelial progenitor cells","volume":"8","author":"Zhou","year":"2013","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01874-7","article-title":"Statins reduce castration-induced bone marrow adiposity and prostate cancer progression in bone","volume":"40","author":"Pan","year":"2021","journal-title":"Oncogene"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.124750","article-title":"Simvastatin improves hematopoietic stem cell engraftment by preventing irradiation-induced marrow adipogenesis and radio-protecting the niche cells","volume":"100","author":"Bajaj","year":"2015","journal-title":"Haematologica"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.5114\/aoms\/158546","article-title":"The effects of statins on the function and differentiation of blood cells","volume":"19","author":"Chamani","year":"2023","journal-title":"Arch Med Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052663","article-title":"The role of endothelial progenitor cells in atherosclerosis and impact of anti-lipemic treatments on endothelial repair","volume":"23","author":"Altabas","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042378","article-title":"Statins-their role in bone tissue metabolism and local applications with different carriers","volume":"25","author":"Granat","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/nu11061394","article-title":"Modulation of bone and marrow niche by cholesterol","volume":"11","author":"Yin","year":"2019","journal-title":"Nutrients"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000018166.84319.55","article-title":"Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells","volume":"105","author":"Walter","year":"2002","journal-title":"Circulation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"104ra1","DOI":"10.1126\/scitranslmed.3002191","article-title":"Diabetes impairs hematopoietic stem cell mobilization by altering niche function","volume":"3","author":"Ferraro","year":"2011","journal-title":"Sci Transl Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201169","article-title":"PU.1 enforces quiescence and limits hematopoietic stem cell expansion during inflammatory stress","volume":"218","author":"Chavez","year":"2021","journal-title":"J Exp Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.60","article-title":"Significance of the absolute lymphocyte\/monocyte ratio as a prognostic immune biomarker in newly diagnosed multiple myeloma","volume":"7","author":"Dosani","year":"2017","journal-title":"Blood Cancer J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1084","article-title":"Diabetes impairs stem cell and proangiogenic cell mobilization in humans","volume":"36","author":"Fadini","year":"2013","journal-title":"Diabetes Care"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1850519\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:55:03Z","timestamp":1780030503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1850519\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":40,"alternative-id":["10.3389\/fendo.2026.1850519"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1850519","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1850519"}}